SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-15-002952
Filing Date
2015-03-30
Accepted
2015-03-30 17:02:25
Documents
16
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2223977z10-k.htm 10-K 1697403
2 EX-10.26 a2223977zex-10_26.htm EX-10.26 103499
3 EX-21.1 a2223977zex-21_1.htm EX-21.1 3532
4 EX-23.1 a2223977zex-23_1.htm EX-23.1 3719
5 EX-31.1 a2223977zex-31_1.htm EX-31.1 7951
6 EX-31.2 a2223977zex-31_2.htm EX-31.2 7920
7 EX-32.1 a2223977zex-32_1.htm EX-32.1 4629
8 EX-32.2 a2223977zex-32_2.htm EX-32.2 4598
15 G688824.JPG g688824.jpg GRAPHIC 54620
16 G19202KII001.JPG g19202kii001.jpg GRAPHIC 3453
  Complete submission text file 0001047469-15-002952.txt   13352350

Data Files

Seq Description Document Type Size
9 EX-101.INS ontx-20141231.xml EX-101.INS 2320690
10 EX-101.SCH ontx-20141231.xsd EX-101.SCH 76183
11 EX-101.CAL ontx-20141231_cal.xml EX-101.CAL 64991
12 EX-101.DEF ontx-20141231_def.xml EX-101.DEF 249115
13 EX-101.LAB ontx-20141231_lab.xml EX-101.LAB 683953
14 EX-101.PRE ontx-20141231_pre.xml EX-101.PRE 475140
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36020 | Film No.: 15735255
SIC: 2834 Pharmaceutical Preparations